Enlivex Therapeutics (ENLV) Stock Highlights

0.98 | -4.85%

2024-11-21 06:25:43

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The companys Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune systems own natural regulation mechanisms.

Statistics

Range Today

0.93 1.11

Volume Today 388.2K

Range 1 Year

1 4.59

Volume 1 Year 28.86M

Range 3 Year

1 8.64

Volume 3 Year 51.13M

Range 10 Year

1 354

Volume 10 Year 223.09M

Highlights

Market Capitalization 26.33M (micro)

Floating Shares 15.6M

Current Price 0.98

Price To Earnings -1.1

Price To Book 0.9

Earnings Per Share -1.14

Payout Ratio 0%

Performance

Latest -4.85%

1 Month -39.51%

3 Months -21.6%

6 Months -30%

1 Year -43.35%

3 Years -87.58%

5 Years -88.9%

10 Years -99.48%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.